HMGCR and myopathy: The estimated incidence of anti-HMGCR antibodies ranges from 1.7 to 10.3 cases per million people per year depending on geographic location, and approximately 6% to 12% of inflammatory myopathy cases from longitudinal and retrospective cohort studies are anti-HMGCR antibody positive [3,8-10].